Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study

OUP accepted manuscript

(2018)   EUROPEAN HEART JOURNAL

The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin

(2017) Mattia Arrigo et al.   EUROPEAN HEART JOURNAL

Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure

(2017) Julio Núñez et al.   Journal of the American Heart Association

Sacubitril/valsartan in PARADIGM-HF

(2017) Nicolas Vodovar et al.   Lancet Diabetes & Endocrinology

Glycaemic control in heart failure: a PARADIGM shift for patients with concomitant diabetes?

(2017) Gregory Giamouzis et al.   Lancet Diabetes & Endocrinology

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial

(2017) Jelena P Seferovic et al.   Lancet Diabetes & Endocrinology

Soluble CD146 Is a Novel Marker of Systemic Congestion in Heart Failure Patients: An Experimental Mechanistic and Transcardiac Clinical Study

(2016) Mattia Arrigo et al.   CLINICAL CHEMISTRY

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure

(2016) Michael R. Zile et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Test in Context: Neprilysin

(2016) Antoni Bayes-Genis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-term neprilysin inhibition — implications for ARNIs

(2016) Duncan J. Campbell   Nature Reviews Cardiology

Unraveling N-Terminal Pro-B-Type Natriuretic Peptide: Another Piece to a Very Complex Puzzle in Heart Failure Patients

(2015) A. S. Jaffe et al.   CLINICAL CHEMISTRY

Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure

(2015) Etienne Gayat et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Soluble Neprilysin Is Predictive of Cardiovascular Death and Heart Failure Hospitalization in Heart Failure Patients

(2015) Antoni Bayés-Genís et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure

(2015) Nicolas Vodovar et al.   JACC-Heart Failure

Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure

(2014) Nicolas Vodovar et al.   EUROPEAN HEART JOURNAL

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics

(2012) Sarah Mangiafico et al.   EUROPEAN HEART JOURNAL

Processing of Pro-Brain Natriuretic Peptide Is Suppressed by O-Glycosylation in the Region Close to the Cleavage Site

(2009) A. G. Semenov et al.   CLINICAL CHEMISTRY

Cross-Reactivity of BNP, NT-proBNP, and proBNP in Commercial BNP and NT-proBNP Assays: Preliminary Observations from the IFCC Committee for Standardization of Markers of Cardiac Damage

(2008) K. N. Luckenbill et al.   CLINICAL CHEMISTRY